BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 26109729)

  • 1. Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.
    Cairns TM; Huang ZY; Gallagher JR; Lin Y; Lou H; Whitbeck JC; Wald A; Cohen GH; Eisenberg RJ
    J Virol; 2015 Sep; 89(18):9213-31. PubMed ID: 26109729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans.
    Cairns TM; Huang ZY; Whitbeck JC; Ponce de Leon M; Lou H; Wald A; Krummenacher C; Eisenberg RJ; Cohen GH
    J Virol; 2014 Nov; 88(21):12612-22. PubMed ID: 25142599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoprotein C of Herpes Simplex Virus 1 Shields Glycoprotein B from Antibody Neutralization.
    Komala Sari T; Gianopulos KA; Nicola AV
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E.
    Hook LM; Huang J; Jiang M; Hodinka R; Friedman HM
    J Virol; 2008 Jul; 82(14):6935-41. PubMed ID: 18480440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-to-Cell Spread Blocking Activity Is Extremely Limited in the Sera of Herpes Simplex Virus 1 (HSV-1)- and HSV-2-Infected Subjects.
    Criscuolo E; Castelli M; Diotti RA; Amato V; Burioni R; Clementi M; Ambrosi A; Mancini N; Clementi N
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus.
    Krawczyk A; Krauss J; Eis-Hübinger AM; Däumer MP; Schwarzenbacher R; Dittmer U; Schneweis KE; Jäger D; Roggendorf M; Arndt MA
    J Virol; 2011 Feb; 85(4):1793-803. PubMed ID: 21123390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repertoire of epitopes recognized by serum IgG from humans vaccinated with herpes simplex virus 2 glycoprotein D.
    Whitbeck JC; Huang ZY; Cairns TM; Gallagher JR; Lou H; Ponce-de-Leon M; Belshe RB; Eisenberg RJ; Cohen GH
    J Virol; 2014 Jul; 88(14):7786-95. PubMed ID: 24789783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global sensing of the antigenic structure of herpes simplex virus gD using high-throughput array-based SPR imaging.
    Cairns TM; Ditto NT; Lou H; Brooks BD; Atanasiu D; Eisenberg RJ; Cohen GH
    PLoS Pathog; 2017 Jun; 13(6):e1006430. PubMed ID: 28614387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of neutralization of herpes simplex virus by antibodies directed at the fusion domain of glycoprotein B.
    Cairns TM; Fontana J; Huang ZY; Whitbeck JC; Atanasiu D; Rao S; Shelly SS; Lou H; Ponce de Leon M; Steven AC; Eisenberg RJ; Cohen GH
    J Virol; 2014 Mar; 88(5):2677-89. PubMed ID: 24352457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for the antibody neutralization of herpes simplex virus.
    Lee CC; Lin LL; Chan WE; Ko TP; Lai JS; Wang AH
    Acta Crystallogr D Biol Crystallogr; 2013 Oct; 69(Pt 10):1935-45. PubMed ID: 24100313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus.
    Du R; Wang L; Xu H; Wang Z; Zhang T; Wang M; Ning Y; Deng F; Hu Z; Wang H; Li Y
    Antiviral Res; 2017 Nov; 147():131-141. PubMed ID: 29061442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope mapping of herpes simplex virus type 2 gH/gL defines distinct antigenic sites, including some associated with biological function.
    Cairns TM; Shaner MS; Zuo Y; Ponce-de-Leon M; Baribaud I; Eisenberg RJ; Cohen GH; Whitbeck JC
    J Virol; 2006 Mar; 80(6):2596-608. PubMed ID: 16501070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge.
    Peng T; Ponce-de-Leon M; Jiang H; Dubin G; Lubinski JM; Eisenberg RJ; Cohen GH
    J Virol; 1998 Jan; 72(1):65-72. PubMed ID: 9420201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linear Multiepitope (Glyco)peptides for Type-Specific Serology of Herpes Simplex Virus (HSV) Infections.
    Risinger C; Sørensen KK; Jensen KJ; Olofsson S; Bergström T; Blixt O
    ACS Infect Dis; 2017 May; 3(5):360-367. PubMed ID: 28238255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera.
    Luo Y; Xiong D; Li HH; Qiu SP; Lin CL; Chen Q; Huang CH; Yuan Q; Zhang J; Xia NS
    Virol J; 2016 Mar; 13():44. PubMed ID: 26987753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using Antibodies and Mutants To Localize the Presumptive gH/gL Binding Site on Herpes Simplex Virus gD.
    Atanasiu D; Saw WT; Lazear E; Whitbeck JC; Cairns TM; Lou H; Eisenberg RJ; Cohen GH
    J Virol; 2018 Dec; 92(24):. PubMed ID: 30282715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs.
    Hook LM; Cairns TM; Awasthi S; Brooks BD; Ditto NT; Eisenberg RJ; Cohen GH; Friedman HM
    PLoS Pathog; 2018 May; 14(5):e1007095. PubMed ID: 29791513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB.
    Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K
    Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.